The combination of insulinotropic actions of GIP with the favorable cardiovascular outcomes and weight reduction of GLP-1 may offer superior glycemic control in the treatment of diabetes mellitus type II [62]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.